Artemis Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3
Closed -$788 68
2022
Q4
$788 Hold
3
﹤0.01% 74
2022
Q3
$676 Hold
3
﹤0.01% 97
2022
Q2
$730 Buy
+3
New +$735 ﹤0.01% 120
2020
Q4
Sell
-25
Closed -$6.4K 72
2020
Q3
$6.4K Buy
+25
New +$6.19K ﹤0.01% 71

Other funds holding AMGN

Artemis Wealth Advisors's AMGN Position: Q1 2023 in Review

Artemis Wealth Advisors sold out of Amgen (AMGN) in Q1 2023, closing a stake of 3 shares — an estimated $788 sold.

Artemis Wealth Advisors first reported a position in AMGN in Q3 2020 and held it in 4 quarters. The position peaked at $6.4K in Q3 2020. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Artemis Wealth Advisors reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Artemis Wealth Advisors sold 3 Amgen shares in Q1 2023, an estimated $788.
  • Artemis Wealth Advisors first reported a position in Amgen in Q3 2020 and held it in 4 quarters.
  • Artemis Wealth Advisors's Amgen position peaked at $6.4K in Q3 2020.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Artemis Wealth Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.